BMS Kidney Transplant Co-Pay Assistance Program: Nulojix - Covered benefit

Coverage RequiredFunded
About
The BMS Kidney Transplant Co-Pay Assistance Program: Nulojix - Covered benefit offers significant financial support for kidney transplant patients prescribed Nulojix. By covering co-pays up to $7,000 annually, the program helps reduce the financial burden associated with outpatient doses of this critical medication. Eligible patients with commercial insurance can greatly benefit from the BMS Kidney Transplant Co-Pay Assistance Program when their insurance does not fully cover the cost, ensuring they have access to Nulojix for the prevention of kidney rejection.
Insurance requirements: Commercially insured
As low as: $50 per fill
Enrollment Forms
Enrollment Form
Benefits
•$7000 annual maximum benefit
Program Requirements
•Valid only for residents in the US and Puerto Rico
•Enrollment Required: Yes
•Coverage Required: Yes
•Needs Based: No
•Activation Required: No
Program Details
•Eligible commercially insured patients pay the first $50 for each outpatient dose of NULOJIX
•Program will cover the remainder of the copay, up to a maximum of $7,000 during a calendar year
•The Program will not cover the cost of any dosing procedure, any other healthcare provider service or supply charges or other treatment costs, or any costs associated with a hospital stay
•In order to receive the copay benefits, Patient or provider must submit an Explanation of Benefits (EOB) form within 180 days of receiving each dose of NULOJIX. The submitted form must include the name of the insurer, plan information, and show that the BMS medication supported by this program was the medication that was given
•Patient may be able to use the program to cover outpatient doses that occurred within 180 days prior to the date of enrollment